Scopus BioPharma Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (16 contracts)
- Business Operations (12)
- Human Resources (3)
- Intellectual Property (7)
- Uncategorized (5)
- Form of Exchange Agreement (Filed With SEC on April 14, 2023)
- Form of Subscription Agreement for Shares of Common Stock (Filed With SEC on April 14, 2023)
- Form of Exchange Agreement (Filed With SEC on October 20, 2022)
- Form of Amendment to the Securities Purchase Agreement, dated as of January 14, 2022, by and among Scopus BioPharma Inc. and the investors named therein (Filed With SEC on January 20, 2022)
- Form of Amendment to the Registration Rights Agreement, dated as of January 14, 2022, by and among Scopus BioPharma Inc. and the investors named therein (Filed With SEC on January 20, 2022)
- Form of Series A Additional Investment Option (Filed With SEC on November 26, 2021)
- Form of Series B Additional Investment Option (Filed With SEC on November 26, 2021)
- Form of Placement Agent Additional Investment Option (Filed With SEC on November 26, 2021)
- Form of Securities Purchase Agreement, dated as of November 21, 2021, by and among Scopus BioPharma Inc. and the investors named therein (Filed With SEC on November 26, 2021)
- Form of Registration Rights Agreement, dated as of November 21, 2021, by and among Scopus BioPharma Inc. and the investors named therein (Filed With SEC on November 26, 2021)
- Warrant Contribution Agreement, dated as of November 23, 2021, by and between Scopus BioPharma Inc. and HCFP/Capital Partners 18B-2 LLC (Filed With SEC on November 26, 2021)
- Indemnification Agreement, dated as of September 26, 2021 (Filed With SEC on September 30, 2021)
- Stock Exchange Agreement, dated June 25, 2021 (Filed With SEC on August 13, 2021)
- ASO Exclusive License Agreement, dated June 25, 2021 (Filed With SEC on August 13, 2021)
- Decoy Exclusive License Agreement, dated June 25, 2021 (Filed With SEC on August 13, 2021)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 29, 2021)
- 2018 Equity Incentive Plan (Filed With SEC on January 28, 2021)
- Employment Agreement for Ashish P. Sanghrajka (Filed With SEC on November 1, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on November 1, 2019)
- Form of Underwriting Agreement (Filed With SEC on August 15, 2019)
- Form of Common Stock Certificate (Filed With SEC on August 15, 2019)
- Form of Warrant Certificate (Filed With SEC on August 15, 2019)
- Form of Warrant Agreement with Continental Stock Transfer and Trust Company (Filed With SEC on August 15, 2019)
- Form of Unit Purchase Option (Filed With SEC on August 15, 2019)
- Form of Series A Unit Certificate (Filed With SEC on August 15, 2019)
- Form of Warrant Issued to Yissum Research Development Corporation of the Hebrew University of Jerusalem, Ltd (Filed With SEC on August 15, 2019)
- Form of Scientific Advisory Board Member Agreement (Filed With SEC on August 15, 2019)
- Clil Medical Ltd. Management Services Agreement (Filed With SEC on August 15, 2019)
- HCFP/Portfolio Services LLC Management Services Agreement (Filed With SEC on August 15, 2019)
- 2018 Equity Incentive Plan (Filed With SEC on August 15, 2019)
- Research and License Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (Filed With SEC on August 15, 2019)
- Memorandum of Understanding for Dr. Alexander Binshtok research with Yissum Research Development Company Hebrew University of Jerusalem Ltd. dated as of July 28, 2018 (Filed With SEC on June 19, 2019)
- Memorandum of Understanding for Dr. Dmitry Tsvelikhovsky with Yissum Research Development Company Hebrew University of Jerusalem Ltd. dated as of July 28, 2018 (Filed With SEC on June 19, 2019)
- Cooperative Research and Development Agreement with the National Institute of Health (Filed With SEC on June 19, 2019)
- Second Amendment to Cooperative Research and Development Agreement (Filed With SEC on June 19, 2019)
- Patent Health Service License Agreement with the National Institute of Health (Filed With SEC on June 19, 2019)
- Research and License Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (Filed With SEC on June 19, 2019)
- Memorandum of Understanding for Dr. Alexander Binshtok research with Yissum Research Development Company Hebrew University of Jerusalem Ltd. dated as of July 28, 2018 (Filed With SEC on June 18, 2019)
- Memorandum of Understanding for Dr. Dmitry Tsvelikhovsky with Yissum Research Development Company Hebrew University of Jerusalem Ltd. dated as of July 28, 2018 (Filed With SEC on June 18, 2019)
- Cooperative Research and Development Agreement with the National Institute of Health (Filed With SEC on June 18, 2019)
- Second Amendment to Cooperative Research and Development Agreement (Filed With SEC on June 18, 2019)
- Patent Health Service License Agreement with the National Institute of Health (Filed With SEC on June 18, 2019)
- Research and License Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (Filed With SEC on June 18, 2019)
